Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors

Clinical Infectious Diseases

Volumn 27, Issue 1, 1998, Pages 65-67

  Roth, Virginia R ^a   Kravcik, Stephen ^a   Angel, Jonathan B ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; HYDROCORTISONE; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TESTOSTERONE CIPIONATE; ZIDOVUDINE;

ADULT; ARTICLE; BIOPSY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE URINE LEVEL; LABORATORY TEST; LYMPHOCYTE COUNT; MALE; NECK MUSCLE; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; SUBCUTANEOUS FAT DISORDER; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0031858419     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514639     Document Type: Article

References (19)

1. McDonald CK, Kuritzkes DR. Human immunodeficiency virus type 1 protease inhibitors. Arch Intern Med 1997;157:951-9.
2. Schapiro JM, Winters MA, Stewart F, et al. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients. Ann Intern Med 1996;124:1039-50.
3. Danner SA, Carr A, Leonard JM, et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. N Engl J Med 1995;333:1528-33.
4. Markowitz M, Saag M, Powderly WG, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease,'to treat HIV-1 infection. N Engl J Med 1995;333:1534-9.
5. Stein DS, Fish DG, Bilello JA, Preston SL, Martineau GL, Drusano GL. A 24-week open-level Phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir). AIDS 1996;10:485-92.
6. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-33.
7. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734-9.
8. Cameron DW, Heath-Chiozzi M, Danner S, et al. Randomized placebocontrolled trial of ritonavir in advanced HIV-1 disease. Lancet 1998;351:543-9.
9. Deeks SG, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors: a review for clinicians. JAMA 1997;277:145-53.
10. Kopp JB, Miller KD, Mican JA, et al. Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med 1997;127:119-25.
11. Daudon M, Estépa L, Viard JP, Joly D, Jungers P. Urinary stones in HIV-1 positive patients treated with indinavir [letter]. Lancet 1997;349:1294-5.
12. Gariano RF, Cooney EL. Uveitis following administration of the protease inhibitor indinavir to a patient with AIDS. Clin Infect Dis 1997;24:529.
13. Brau N, Leaf HL, Wieczorek RK, Margolis DM. Severe hepatitis in three AIDS patients treated with indinavir [letter]. Lancet 1997;349:924-5.
14. Matsuda J, Gohchi K, Yamanaka M. Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir [letter]. Lancet 1997;350:364.
15. Lewis JS, Terriff CM, Coulston DR, Garrison MW. Protease inhibitors: a therapeutic breakthrough for the treatment of patients with human immunodeficiency virus. Clin Ther 1997;19:187-214.
16. Sullivan AK, Nelson MR. Marked hyperlipidemia on ritonavir therapy [letter]. AIDS 1997;11:938-9.
17. Talley CR, ed. Protease inhibitors may raise blood glucose levels, FDA warns. Am J Health Syst Pharm 1997;54:1575.
18. Jimenez-Expósito MJ, Paul A, Laville A, Masana L. Nonactivity of hepatic lipase during a treatment with ritonavir [abstract no 733]. In: Program and abstracts of the Sixth European Conference on Clinical Aspects and Treatment of HIV Infection (Hamburg, Germany). European AIDS Clinical Society, 1997:146.
19. Herry I, Bernard L, de Truchis P, Perronne C. Hypertrophy of the breasts in a patient treated with indinavir. Clin Infect Dis 1997;25:937-8.